| | | |  | | | | By Elizabeth Cooney Adobe The CDC puts it as high as 1 in 5 adults. Here are some factors that make the range of estimates easier to understand. Read More | | By Katie Palmer Mike Groll/AP The IBM Watson Health brand comes with baggage. But for its new owners, the core assets are the primary selling point for a new business. Read More | | By Jason Mast Adobe Vertex, they say, has not released key information on precisely how CRISPR is impacting the DNA of patients in its trials. Read More | | Sponsor content by Dermavant Biologics have dominated headlines. Now the spotlight's on a new topical for plaque psoriasis Dermavant Sciences announced the FDA approval of their novel topical treatment for adults with mild, moderate, and severe plaque psoriasis – the first and only FDA-approved steroid free topical medication in its class. In clinical trials the treatment demonstrated statistically significant results across primary and secondary endpoints versus vehicle, with no label restrictions on duration of use, body surface area, and an approximately four month off-treatment remittive effect (median time to first worsening). Learn more here. | | By Sarah Mupo Alex Hogan/STAT Summer's a great time to dig into a new book or podcast, and we have you covered with our annual list of health, medicine, and science titles. Read More | | By Jorge A. Caballero CHRIS DELMAS/AFP via Getty Images The FDA needs to explain why it didn't authorize the use of Moderna's Covid-19 vaccine for kids under age 5 sooner than it did. Read More | | By Paul Chaplin Adobe The development of a monkeypox vaccine emerged from U.S. investing in medical countermeasures after the September 11 attacks in 2001. Read More | | By Heather Brace and Vivek Sharma Adobe Investment in career education can be an effective approach to recruiting and retaining health care workers. Read More | |
No comments